| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics, Inc. | President and CEO, Director | Common Stock | 0 | $0 | $2.51 | Sep 18, 2024 | Direct |
| G1 Therapeutics, Inc. | President and CEO, Director | Stock Option (right to buy) | 0 | Sep 18, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GTHX | G1 Therapeutics, Inc. | Sep 18, 2024 | 5 | $0 | 4 | Sep 18, 2024 | President and CEO, Director |
| GTHX | G1 Therapeutics, Inc. | Jul 5, 2024 | 1 | -$19.2K | 4 | Jul 8, 2024 | President and CEO, Director |
| GTHX | G1 Therapeutics, Inc. | Jul 1, 2024 | 1 | $0 | 4 | Jul 3, 2024 | President and CEO, Director |
| GTHX | G1 Therapeutics, Inc. | May 13, 2024 | 1 | -$178K | 4 | May 15, 2024 | President and CEO, Director |
| GTHX | G1 Therapeutics, Inc. | Jan 3, 2024 | 4 | -$36.4K | 4 | Jan 8, 2024 | President and CEO, Director |
| GTHX | G1 Therapeutics, Inc. | Jan 2, 2024 | 1 | -$108K | 4 | Jan 2, 2024 | President and CEO, Director |
| GTHX | G1 Therapeutics, Inc. | Jul 5, 2023 | 1 | -$6.67K | 4 | Jul 7, 2023 | President and CEO, Director |
| GTHX | G1 Therapeutics, Inc. | May 10, 2023 | 1 | $0 | 4 | May 12, 2023 | President and CEO, Director |
| GTHX | G1 Therapeutics, Inc. | Jan 3, 2023 | 4 | -$219K | 4 | Jan 5, 2023 | President and CEO, Director |
| GTHX | G1 Therapeutics, Inc. | Jan 3, 2022 | 3 | -$355K | 4 | Jan 5, 2022 | President and CEO, Director |